Medpace Holdings (MEDP) Interest & Investment Income (2015 - 2026)
Medpace Holdings (MEDP) reported Interest & Investment Income of $5.1 million for Q1 2026, down 20.83% on a YoY basis from $6.5 million in Q1 2025, and up 37.48% quarter-over-quarter from $3.7 million in Q4 2025.
Medpace Holdings (MEDP) Interest & Investment Income (2015 - 2026) Analysis & Trends
Medpace Holdings has reported Interest & Investment Income for 12 years, with the latest figure at $5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 20.83% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $11.4 million (down 58.18% YoY), and the FY2025 full-year result was $12.8 million, down 48.87% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $5.1 million, up from $3.7 million in the prior quarter.
- The five-year high for Interest & Investment Income was $7.9 million in Q4 2024, with the low at -$1.6 million in Q3 2022.
- Historically, Interest & Investment Income has averaged $2.3 million across 5 years, with a median of $1.5 million in 2025.
- Annual changes were most pronounced in 2022 — Interest & Investment Income sank 3763.41% — and 2024, when it soared 7269.52%.
- Medpace Holdings' Interest & Investment Income stood at -$827000.0 in 2022, then surged by 322.97% to $1.8 million in 2023, then soared by 327.49% to $7.9 million in 2024, then plunged by 52.78% to $3.7 million in 2025, then surged by 37.48% to $5.1 million in 2026.
- The last three Interest & Investment Income figures came in at $5.1 million (Q1 2026), $3.7 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 6.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 233.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 27.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 597,000.00 |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 13.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 10.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 11.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Medpace Holdings | 13.30 Bn | 12.64 Bn | 196.33 Mn | 5.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 3.72 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 6.46 Mn |
| Dec 31, 2024 | 7.88 Mn |
| Sep 30, 2024 | 7.53 Mn |
| Jun 30, 2024 | 5.47 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | -105,000.00 |
| Jun 30, 2023 | -1.37 Mn |
| Mar 31, 2023 | -861,000.00 |
| Dec 31, 2022 | -827,000.00 |
| Sep 30, 2022 | -1.58 Mn |
| Jun 30, 2022 | -548,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | -23,000.00 |
| Sep 30, 2021 | -41,000.00 |
| Jun 30, 2021 | -27,000.00 |